FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Deutsche Boerse AG 01:12:27 29/06/2024 am IST | ||
| 0.034 EUR | +3.03% |
|
| Current month | -15.00% | ||
| 1 month | -20.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 0.034 | +3.03% |
| 27/24/27 | 0.033 | -.--% |
| 26/24/26 | 0.033 | +10.00% |
| 25/24/25 | 0.03 | -6.25% |
| 24/24/24 | 0.032 | -11.11% |
Delayed Quote Deutsche Boerse AG
Last update June 29, 2024 at 01:12 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB0XS5 |
| ISIN | DE000SB0XS55 |
| Date issued | 08/06/2020 |
| Strike | 220.8 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.87 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.85 € |
|---|---|
| Lowest since issue | 0.027 € |
| Spread | 0.01 € |
| Spread % | 22.73% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
